Tech Company Financing Transactions

MacroGenics Funding Round

MacroGenics closed a $25 million Series D financing round on 9/25/2008. Investors included Alta Partners, Innovis Investments and InterWest Partners.

Transaction Overview

Company Name
Announced On
9/25/2008
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series D
Proceeds Purpose
MacroGenics expects to use the proceeds from this financing to fund the cancer stem cell program it acquired through its acquisition of Raven Biotechnologies in July. In addition, the proceeds will be used to further advance the company's autoimmune, cancer and infectious disease product candidate portfolio, as well as for general working capital purposes.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9640 Medical Center Dr.
Rockville, MD 20850
USA
Email Address
Overview
MacroGenics is a private, venture-backed biotechnology company headquartered in Rockville, Maryland that focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.
Profile
MacroGenics LinkedIn Company Profile
Social Media
MacroGenics Company Twitter Account
Company News
MacroGenics News
Facebook
MacroGenics on Facebook
YouTube
MacroGenics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Scott Koenig
  Scott  Koenig LinkedIn Profile  Scott  Koenig Twitter Account  Scott  Koenig News  Scott  Koenig on Facebook
Chief Financial Officer
James Karrels
  James Karrels LinkedIn Profile  James Karrels Twitter Account  James Karrels News  James Karrels on Facebook
Controller
Lynn Cilinski
  Lynn Cilinski LinkedIn Profile  Lynn Cilinski Twitter Account  Lynn Cilinski News  Lynn Cilinski on Facebook
VP - Bus. Development
Eric Risser
  Eric Risser LinkedIn Profile  Eric Risser Twitter Account  Eric Risser News  Eric Risser on Facebook
VP - R & D
Ezio Bonvini
  Ezio  Bonvini LinkedIn Profile  Ezio  Bonvini Twitter Account  Ezio  Bonvini News  Ezio  Bonvini on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/25/2008: Purewire venture capital transaction
Next: 9/25/2008: Verimatrix venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC transactions on this site are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary